NovelMed Therapeutics is a privately held biotechnology company that has developed cutting-edge highly selective therapeutics for complement-mediated diseases.
Looking for a particular NovelMed employee's phone or email?
The NovelMed annual revenue was $5.1 million in 2026.
Rekha Bansal is the CEO of NovelMed.
5 people are employed at NovelMed.
NovelMed is based in Cleveland, Ohio.
The NAICS codes for NovelMed are [54, 541713, 5417, 54171, 541].
The SIC codes for NovelMed are [873, 87].